What does the evidence say about Pomegranate Supplementation Blood Pressure Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Pomegranate Supplementation Blood Pressure Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - However, current clinical evidence remains inconclusive, with meta-analyses revealing heterogeneity in intervention outcomes across randomized controlled trials. [Wu D (2025); evidence level 1] - These results provide graded evidence for personalized nutritional interventions, promoting the transformation of polyphenol preparations from dietary supplements to precision adjuvant therapies. [Wu D (2025); evidence level 1] - Background The therapeutic application of dietary polyphenols in chronic obstructive pulmonary disease (COPD) management represents an emerging therapeutic paradigm in pulmonary medicine. [Wu D (2025); evidence level 1] - Thus, the aim of our study is to evaluate the effects of pomegranate peel extract (PP) supplementation on hepatic status and metabolic syndrome risk factors. [Barghchi H (2023); evidence level 2] - Introduction Non-alcoholic fatty liver disease (NAFLD) is a metabolic syndrome (MS)-related liver disorder that has an increasing prevalence. [Barghchi H (2023); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.